2.
总人群中各指标预测Gleason 评分≥7的前列腺癌的效能
Value of each index for predicting PCa patients (in total) with Gleason score≥7
| Items | Cut-off value | AUC | 95%CI | Sensitivity/% | Specificity/% |
| tPSA, total prostate-specific antigen; fPSA, free prostate-specific antigen; f/t, fPSA/tPSA; p2PSA, isoform [-2] proprostate-specific antigen; %p2PSA, p2PSA/(fPSA×1 000)×100; PHI, prostate health index; AUC, area under curve. | |||||
| tPSA/(μg/L) | 9.76 | 0.648 | 0.592 - 0.701 | 63.8 | 67.6 |
| fPSA/(μg/L) | 1.25 | 0.536 | 0.476 - 0.589 | 50.3 | 58.9 |
| f/t | 0.16 | 0.693 | 0.639 - 0.744 | 73.1 | 51.4 |
| p2PSA/(ng/L) | 29.39 | 0.673 | 0.618 - 0.725 | 67.2 | 72.9 |
| %p2PSA | 1.68 | 0.770 | 0.719 - 0.815 | 83.3 | 74.9 |
| PHI | 64.00 | 0.760 | 0.709 - 0.806 | 81.1 | 78.4 |